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1. Introduction: Tendinopathies, especially upper patellar tendinopathy 
also known as jumper’s knee, often remain rebel to conservative 
treatments. Several experimental studies have shown the healing 
properties of platelet and their growth factors. These factors have the 
potentiality to improve healing of different tissues: bones, muscles, 
tendons... Researches have specifically demonstrated the platelets action 
as mediator and/or enhancer of tissue healing. On the other hand, such 
treatment has been totally removed of list of doping treatments. The aim 
of our study was to investigate the effect of 1 injection of PRP in 
patients suffering from chronic jumper’s knee.
4. Conclusion: One in situ injection of PRP clinically improved patients 
with jumper’s knee 6 weeks after treatment. Most patients reported a 
decrease of pain during day-life and through physical activities. However 
nor functional performances neither imaging were improved. A followup at 
3 months is actually in process to evaluate more long term efficacy of PRP 
treatment.
2. Methods: Patients performed imaging (US and MRI) and functional 
assessments, and a clinical examination using an algometer, before 
treatment and 6 weeks after PRP treatment (cf figures). They were also 
invited to answer to questionnaire relative to pain and functional status. 
PRP was obtained from autologous blood using an apheresis system 
(COM.TEC, Fresenius). The injection of 6mL of PRP was realised without 
local anaesthesia into the proximal insertion of the patellar tendon. A 48h 
rest-time was recommended after infiltration. Afterwards, a submaximal 
eccentric reeducation was initiated 1 week after infiltration 3 times a week 
during 5 weeks. In case of pain, anti-inflammatory drugs were prohibited 
and patient were encouraged to take class I or II painbrakers. Our protocol 
was approved by Ethic Committee of University and University Hospital of 
Liège (Belgium).
3. Results: Eighteen patients with jumper’s knee were included in our 
study. Pre-injection tests revealed pain of the upper part of the patellar 
tendon just below the patella, associated with loss of function. Imaging 
exams confirmed diagnosis. Six weeks post-injection, the clinical status 
was improved for the majority of the patients, with a significant 
decrease of algo-functional scores. The pain reported during functional 
assessments was decreased (in particular for the eccentric actions), yet 
no significant improvement of physical performances was observed. We 
found no significant differences between imaging exams before and 6 
weeks after PRP injection.
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